Rollins, Inc.
—- Market cap
- —
- Debt
- +$609.83M
- Cash
- −$100.00M
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: ROL stock price vs KMB: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at KMB's multiple
Needs KMB P/E.
Implied fair value · at ROL's multiple
Needs ROL P/E.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Nine period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
ROLLINS, INC. · implied price per share
Bear
$14.27
Base
$16.97
Bull
$20.49
KIMBERLY-CLARK CORPORATION · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
ECOLAB INC.
ROL vs ECL
HOME DEPOT, INC.
ROL vs HD
Serve Robotics Inc. /DE/
ROL vs SERV
CINTAS CORP
ROL vs CTAS
IRON MOUNTAIN INC
ROL vs IRM
MAXIMUS, INC.
ROL vs MMS
Procter & Gamble Company
ROL vs PG
COLGATE PALMOLIVE CO
ROL vs CL
CLOROX CO /DE/
ROL vs CLX
CHURCH & DWIGHT CO INC /DE/
ROL vs CHD
EDGEWELL PERSONAL CARE Co
ROL vs EPC
Johnson & Johnson
ROL vs JNJ
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe ROL can sustain its 11.0% revenue growth and 38.5% ROIC without multiple compression, then holding may still make sense; otherwise, the current 34.5x P/E versus KMB's 18.0x suggests trimming or avoiding the stock because the valuation premium is not fully supported by the relative data.
ROL trades at a large premium to KMB on earnings, sales, and EBITDA despite the model implying a much lower value. The current price of $37.57 versus implied P/E value of $19.59 suggests the market is paying for quality, but KMB and range data point to that premium being stretched.
Supporting Metrics